Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

9 Jan 2015 07:00

RNS Number : 7095B
MJ Gleeson PLC
09 January 2015
 



MJ GLEESON PLC

('Gleeson' or 'the Group')

TRADING UPDATE

 

MJ Gleeson plc (GLE.L), the urban regeneration and strategic land specialist, today issues the following trading update ahead of its interim results for the six months ended 31 December 2014, which will be announced on Wednesday 25th February 2015.

 

The Group continues to trade well and expects profits for H1 2015 to show a strong increase over H1 2014.

 

Gleeson Homes

 

Market conditions remain healthy, with strong customer demand in all of our regions.

 

We continued to make strong progress in the period, selling 321 homes, an increase of 24% on the previous year's total of 258.

 

The current forward order book of 299 units is an increase of 23% over the previous year's figure of 240 and, as previously announced, the Board expects to record an increase in completions in the year to 30 June 2015 of not less than 25% against the prior year total of 561 units.

 

The business currently has 39 active sites, compared with 33 in the corresponding period.

 

The land pipeline of owned and conditionally purchased plots at 31 December 2014 increased by 30% compared to the prior year, totalling 5,267 plots, of which 1,588 plots have been purchased subject to planning permission. In addition, there are a further 1,900 plots which are in the pipeline to be acquired.

 

Gleeson Strategic Land

 

During the period we sold a 15 acre site with planning permission for 51 plots, along with the sale of 1.5 acres of commercial land from our site in Thanet, Kent.

 

There are currently eight sites in the portfolio with planning permission or a resolution to grant permission. Six of these sites, which will deliver 672 plots, are being progressed for sale in the current financial year.

 

In addition, there are 13 sites where the business is currently awaiting either the determination of a planning application or the outcome of a planning appeal. It may also be possible to sell a number of these sites in the current financial year.

 

Jolyon Harrison, Chief Executive, commented:

 

"The first half performance of both Gleeson Homes and Gleeson Strategic Land has been encouraging as we continue to benefit from our focussed, twin track strategy of providing low cost family homes in the North of England, and strategic land promotion in the South. We expect to report a result for the full year in line with current expectations."

 

9 January 2015

 

 

 

 

Enquiries:

 

MJ Gleeson plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

Instinctif Partners

Tel: +44 20 7457 2020

Helen Tarbet

Mark Garraway

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Gillian Martin

 

 

 

Notes to Editors

 

MJ Gleeson plc operates in the house building sector through the following business units: Gleeson Homes, which focuses on estate regeneration and housing development on brownfield land in the North of England; and Gleeson Strategic Land, which purchases options over land in the South of England with the objective of enhancing the value of the site concerned by securing residential planning permission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUMCGUPAGQR
Date   Source Headline
20th Feb 20189:37 amRNSHolding(s) in Company
19th Feb 20187:00 amRNSHalf-year Report
7th Feb 20184:40 pmRNSSecond Price Monitoring Extn
7th Feb 20184:35 pmRNSPrice Monitoring Extension
7th Feb 20182:21 pmRNSDirector/PDMR Shareholding
31st Jan 20187:00 amRNSTotal Voting Rights
10th Jan 20182:10 pmRNSDirector/PDMR Shareholding
4th Jan 20187:00 amRNSTrading Update
29th Dec 20177:00 amRNSTotal Voting Rights
8th Dec 201711:51 amRNSDirector/PDMR Shareholding
8th Dec 20178:53 amRNSDirector/PDMR Shareholding
7th Dec 20174:26 pmRNSResult of AGM
7th Dec 20177:00 amRNSAGM Statement
30th Nov 20177:00 amRNSTotal Voting Rights
23rd Nov 20175:48 pmRNSDirector/PDMR Shareholding
23rd Nov 20175:44 pmRNSHolding(s) in Company
8th Nov 20174:54 pmRNSDirector/PDMR Shareholding
8th Nov 20174:43 pmRNSHolding(s) in Company
8th Nov 20174:25 pmRNSDirector/PDMR Shareholding
6th Nov 20177:00 amRNSNotice of AGM
31st Oct 20177:00 amRNSTotal Voting Rights
6th Oct 20172:07 pmRNSDirector/PDMR Shareholding
4th Oct 201711:31 amRNSExercise of Options, TVR & Director/PDMR Dealings
29th Sep 20177:00 amRNSTotal Voting Rights
26th Sep 20174:06 pmRNSPerformance Share Plan Award to Directors
25th Sep 20177:00 amRNSFinal Results
8th Sep 20174:35 pmRNSPrice Monitoring Extension
7th Sep 20179:59 amRNSDirector/PDMR Shareholding
31st Aug 20177:00 amRNSTotal Voting Rights
23rd Aug 201712:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201712:02 pmRNSPrice Monitoring Extension
22nd Aug 20174:35 pmRNSPrice Monitoring Extension
9th Aug 20179:13 amRNSDirector/PDMR Shareholding
31st Jul 20177:00 amRNSTotal Voting Rights
18th Jul 20174:55 pmRNSDirector/PDMR Shareholding
7th Jul 201710:06 amRNSDirector/PDMR Shareholding
5th Jul 20177:00 amRNSTrading Update
30th Jun 20177:00 amRNSTotal Voting Rights
6th Jun 20175:17 pmRNSDirector/PDMR Shareholding
31st May 20177:00 amRNSTotal Voting Rights
25th May 20171:27 pmRNSDirector/PDMR Shareholding
11th May 20171:11 pmRNSDirector/PDMR Shareholding
28th Apr 20177:00 amRNSTotal Voting Rights
24th Apr 20178:49 amRNSHolding(s) in Company
6th Apr 20176:11 pmRNSDirector/PDMR Shareholding
31st Mar 20177:00 amRNSTotal Voting Rights
7th Mar 20175:10 pmRNSDirector/PDMR Shareholding
3rd Mar 20176:14 pmRNSHolding(s) in Company
28th Feb 20177:00 amRNSTotal Voting Rights
27th Feb 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.